Drug-Specific Th2 Cells and IgE Antibodies in a Patient with Anaphylaxis to Rituximab-Reference-Cited by-同舟云学术

Drug-Specific Th2 Cells and IgE Antibodies in a Patient with Anaphylaxis to Rituximab

Published:2012 Issue:3 Volume:159 Page:321-326
ISSN:1423-0097
Container-title:International Archives of Allergy and Immunology
language:en
Short-container-title:Int Arch Allergy Immunol

Author:

Vultaggio Alessandra,Matucci Andrea,Nencini Francesca,Pratesi Sara,Petroni Giulia,Cammelli Daniele,Alterini Renato,Rigacci Luigi,Romagnani Sergio,Maggi Enrico

Publisher

S. Karger AG

Subject

Immunology,General Medicine,Immunology and Allergy

Reference18 articles.

1. Monoclonal antibody-induced cytokine-release syndrome

2. Hypersensitivity reactions to mAbs: 105 desensitizations in 23 patients, from evaluation to treatment

3. Infusion Reactions

4. Immunogenicity of rituximab in patients with severe pemphigus

5. Monitoring patients treated with anti-TNF- biopharmaceuticals: assessing serum infliximab and anti-infliximab antibodies

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of the inhibitory effects between bepotastine and diphenhydramine on rituximab-induced infusion-related reactions: A single-center retrospective study;2024-09-11

2. The Efficacy of Bepotastine Besilate Compared With Hydroxyzine Pamoate for Preventing Infusion Reactions to the First Dose of Rituximab in Patients With Non-Hodgkin Lymphoma: Protocol for a Phase II, Double-Blind, Multicenter Randomized Trial;JMIR Research Protocols;2024-02-22

3. Immediate hypersensitivity reactions to antineoplastic agents – A practical guide for the oncologist;Cancer Treatment Reviews;2023-05

4. Rituximab and infliximab desensitization with anti-IgE mAb omalizumab as adjuvant therapy: a case series;The Journal of Allergy and Clinical Immunology: In Practice;2022-12

5. Standards for practical intravenous rapid drug desensitization & delabeling: A WAO committee statement;World Allergy Organization Journal;2022-06